GlobeNews Wire

Contemporary Care Introduces TMS Therapy to Naples, Florida

Image by Contemporary Care NAPLES, Fla., Oct. 03, 2025 (GLOBE NEWSWIRE) -- Contemporary Care today announced the availability of Transcranial…

6 months ago

Publication relating to transparency notifications

REGULATED INFORMATION Publication relating to transparency notifications Mont-Saint-Guibert (Belgium), October 3, 2025, 10:30 pm CET / 4:30 pm ET –…

6 months ago

Context Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

October 03, 2025 16:15 ET  | Source: Context Therapeutics Inc. PHILADELPHIA, Oct. 03, 2025 (GLOBE NEWSWIRE) -- Context Therapeutics Inc.…

6 months ago

Mobix Labs Goes on Offense: Launches Aggressive Acquisition Strategy with Access to $100 Million+

October 03, 2025 07:00 ET  | Source: Mobix Labs, Inc. ~ Bold 2026 strategy targets game-changing acquisitions and new revenue…

6 months ago

Swift and Wowza Bring Seamless Streaming to the Worlds Most Isolated Locations

DENVER and WEST PERTH, Australia, Oct. 03, 2025 (GLOBE NEWSWIRE) -- Swift, a leader in remote content delivery, has partnered…

6 months ago

Ethereum Startup AgoraLend Opens Fresh Fundraise After Oversubscribed $300,000 Round

DUBAI, United Arab Emirates, Oct. 03, 2025 (GLOBE NEWSWIRE) -- AgoraLend is modernizing traditional lending through decentralized finance (DeFi) on…

6 months ago

Angelini Ventures Leads 12 Million Follow-On Investment in Serenis, a Fast-Growing Digital Mental and Physical Health Company

Through its investment, Angelini Ventures aims to promote the expansion and acceleration of Serenis’ digital health and wellbeing services and…

6 months ago

Appointment of Marc Le Bozec as Interim CEO

Appointment of Marc Le Bozec as Interim CEO Nantes, October 3, 2025, 8:00 a.m. CET – OSE Immunotherapeutics (ISIN: FR0012127173;…

6 months ago

FDA approves Roches Tecentriq plus lurbinectedin as first-line maintenance therapy for extensive-stage small cell lung cancer

Combination reduced the risk of disease progression or death by 46% and risk of death by 27% in pivotal phase…

6 months ago

Cirrus Therapeutics Raises $11 M Seed Financing to Advance Novel Ocular Gene Therapy to Reverse Underlying Age-Related Cause of Dry AMD

October 02, 2025 10:00 ET  | Source: Cirrus Therapeutics, Inc. Cirrus’ lead program is a novel AAV gene therapy designed…

6 months ago